Active pharmaceutical ingredients (API) for biologics are witnessing rapid growth as pharmaceutical companies focus on the development of advanced therapeutics. APIs biologics were traditionally ...

American entrepreneur and investor Mark Cuban tells us why he and his partners launched the Mark Cuban Cost Plus Drug Company (MCCPDC ... is that there's a long list of middlemen that obfuscate ...

The Federal Trade Commission sued on Friday the three largest pharmaceutical intermediaries charged with negotiating drug ...

Pharmaceutical stocks largely shook off the brunt of negotiated drug prices. But that doesn't mean they'll be spared election noise.

Table 1. List of Unapproved Drugs Available In the US Market in 201011 *Drugs against which FDA enforcement actions were taken.12 In 2011, the FDA issued a Revised Guidance to clarify that ...

Ebglyss is a new biologic treatment for moderate-to-severe eczema that isn’t controlled with topical therapies. The ...

The Central Drugs Standard Control Organization has published details of samples declared 'Not of Standard Quality' (NSQ) by ...

When President Donald Trump’s administration tried to get drugmakers to list the price of any treatments costing ... The FDA has two offices whose duties include scrutinizing drug advertising for ...

When CMS begins negotiations for physician-administered drugs under the Inflation Reduction Act, providers, including those ...

In its latest warning letter, FDA raised concern that the company was still producing eye drops with amniotic fluid, even ...

ADMA stock surges 76.2% in three months on strong performance and high growth prospects. It recently hit its 52-week high ...